(Q80103622)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906574%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Discordant results of flow cytometric ZAP-70 expression status in B-CLL samples if different gating strategies are applied (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906574%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

B-cell chronic lymphocytic leukemia

1 reference

Christian Wilhelm

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906574%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Andreas Neubauer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906574%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Cornelia Brendel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906574%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 July 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906574%20AND%20SRC:MED&resulttype=core&format=json

Cytometry Part B: Clinical Cytometry

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906574%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906574%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906574%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

242-250

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906574%20AND%20SRC:MED&resulttype=core&format=json

Chronic Lymphocytic Leukemia

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

ZAP-70 is expressed by a subset of normal human B-lymphocytes displaying an activated phenotype

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

ZAP-70 expression and prognosis in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

A robust ratio metric method for analysis of Zap-70 expression in chronic lymphocytic leukemia (CLL)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

Comparison of flow cytometric methods for the measurement of ZAP-70 expression in a routine diagnostic laboratory

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

T-cell ZAP-70 overexpression in chronic lymphocytic leukemia (CLL) correlates with CLL cell ZAP-70 levels, clinical stage and disease progression

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20123

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.20123

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16906574%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference